The future of nanotechnology in oncology looks promising. Ongoing research is focused on developing more sophisticated nanocarriers and enhancing their efficiency. The integration of artificial intelligence and machine learning with nanotechnology could lead to highly personalized cancer therapies. As our understanding of the interactions between nanoparticles and biological systems improves, the clinical translation of these technologies will likely accelerate.
